Daniel A. Camardo, EVP and President, U.S at Horizon Therapeutics Public Ltd Co (HZNP), sold 25,800 shares at $85.88 ($2.2M) on 2021-03-30, disclosed to the SEC on 2021-03-31.
Open-market sale of $2.2M HZNP by EVP and President, U.S. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $83.58 | 1,803 | $151K | 6.8% |
| 2 | $83.58 | 1,803 | $151K | 6.8% |
| 3 | $84.97 | 4,594 | $390K | 17.7% |
| 4 | $84.97 | 4,594 | $390K | 17.7% |
| 5 | $85.88 | 2,986 | $256K | 11.6% |
| 6 | $85.88 | 2,986 |
| $256K |
| 11.6% |
| 7 | $86.87 | 3,517 | $306K | 13.8% |
| 8 | $86.87 | 3,517 | $306K | 13.8% |
| Total | $85.50 avg | 25,800 | $2.2M | 100% |
| Filing → |
| HZNP | SELL | 2020-11-06 | $269K | — | Filing → |